“软硬”兼施发力基础研究 亚辉龙在高端IVD赛道上“发光”

Core Viewpoint - The company, Aihuilong, is shifting its development strategy from rapid market capture to a focus on research and innovation, aiming for high-quality growth in the IVD industry amidst fierce competition [2][10]. Group 1: Research and Development - Aihuilong is enhancing its foundational research capabilities to overcome challenges in the IVD industry, which is characterized by weak innovation and low barriers to entry [3]. - The company has established six R&D centers across major cities in China and Japan, strengthening its industry chain from raw material development to product sales [3]. - Aihuilong's R&D investment from 2021 to 2024 is expected to exceed 1 billion yuan, with annual R&D spending accounting for over 20% of its main business revenue [3]. Group 2: Product Innovation - Aihuilong has registered 62 chemical luminescence self-immune testing reagent projects, establishing a competitive advantage in rare disease diagnostics [4]. - The company is collaborating with top research teams to develop innovative diagnostic tools, including a groundbreaking test for heart failure that is set to enter the market by 2026 [6][7]. Group 3: Market Expansion - Aihuilong is actively pursuing international markets, with overseas revenue surpassing 200 million yuan in the first three quarters of the year, reflecting a nearly 40% year-on-year growth [8]. - The company is forming partnerships with international universities to enhance its global innovation capabilities and compete in high-end medical markets [7]. Group 4: AI Integration - Aihuilong is implementing an "AI + IVD" strategy to address challenges in chronic disease management, focusing on the needs of an aging population [9]. - The company has launched integrated diagnostic solutions for type 1 diabetes in collaboration with Sanofi, aiming to transition from passive treatment to proactive intervention [9]. Group 5: Strategic Vision - Aihuilong is committed to becoming a leading international IVD enterprise by continuously enhancing its core competitiveness and aligning its technology with market demands [10].